NBIX logo

Neurocrine Biosciences (NBIX) Long term debt

Annual long term debt:

$455.10M+$196.80M(+76.19%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NBIX annual long term debt is $455.10 million, with the most recent change of +$196.80 million (+76.19%) on December 31, 2024.
  • During the last 3 years, NBIX annual long term debt has risen by +$14.70 million (+3.34%).
  • NBIX annual long term debt is now at all-time high.

Performance

NBIX Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Quarterly long term debt:

$447.50M-$7.60M(-1.67%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NBIX quarterly long term debt is $447.50 million, with the most recent change of -$7.60 million (-1.67%) on March 31, 2025.
  • Over the past year, NBIX quarterly long term debt has increased by +$194.60 million (+76.95%).
  • NBIX quarterly long term debt is now -10.45% below its all-time high of $499.70 million, reached on March 31, 2020.

Performance

NBIX Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

NBIX Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+76.2%+77.0%
3 y3 years+3.3%-6.8%
5 y5 years+424.9%-10.4%

NBIX Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+386.7%-6.8%+420.9%
5 y5-yearat high+424.9%-10.4%+439.2%
alltimeall timeat high>+9999.0%-10.4%>+9999.0%

NBIX Long term debt History

DateAnnualQuarterly
Mar 2025
-
$447.50M(-1.7%)
Dec 2024
$455.10M(+76.2%)
$455.10M(+81.0%)
Sep 2024
-
$251.40M(-1.9%)
Jun 2024
-
$256.20M(+1.3%)
Mar 2024
-
$252.90M(-2.1%)
Dec 2023
$258.30M(+176.3%)
$258.30M(+200.7%)
Sep 2023
-
$85.90M(-3.6%)
Jun 2023
-
$89.10M(-65.7%)
Mar 2023
-
$259.90M(+178.0%)
Dec 2022
$93.50M(-78.8%)
$93.50M(-3.2%)
Sep 2022
-
$96.60M(-64.0%)
Jun 2022
-
$268.60M(-44.1%)
Mar 2022
-
$480.20M(+9.0%)
Dec 2021
$440.40M(+6.8%)
$440.40M(+0.8%)
Sep 2021
-
$437.10M(+0.4%)
Jun 2021
-
$435.30M(+1.4%)
Mar 2021
-
$429.50M(+4.2%)
Dec 2020
$412.30M(+375.5%)
$412.30M(+396.7%)
Sep 2020
-
$83.00M(-1.5%)
Jun 2020
-
$84.30M(-83.1%)
Mar 2020
-
$499.70M(+476.4%)
Dec 2019
$86.70M(-77.7%)
$86.70M(-81.9%)
Sep 2019
-
$478.07M(+2.9%)
Jun 2019
-
$464.65M(+0.9%)
Mar 2019
-
$460.58M(+18.6%)
Dec 2018
$388.50M(+5.1%)
$388.50M(+2.5%)
Jun 2018
-
$378.88M(+1.2%)
Mar 2018
-
$374.21M(+1.2%)
Dec 2017
$369.62M(+4810.6%)
$369.62M(+1.2%)
Sep 2017
-
$365.11M(+1.2%)
Jun 2017
-
$360.68M(+7938.4%)
Sep 2010
-
$4.49M(-11.9%)
Jun 2010
-
$5.09M(-17.4%)
Mar 2010
-
$6.16M(-26.4%)
Sep 2009
-
$8.38M(+204.7%)
Jun 2009
-
$2.75M(-8.8%)
Mar 2009
-
$3.02M(-59.9%)
Dec 2008
$7.53M
$7.53M(-84.1%)
DateAnnualQuarterly
Sep 2007
-
$47.44M(-1.0%)
Jun 2007
-
$47.93M(-1.2%)
Mar 2007
-
$48.53M(-1.3%)
Dec 2006
$49.15M(-8.3%)
$49.15M(-1.9%)
Sep 2006
-
$50.13M(-2.1%)
Jun 2006
-
$51.20M(-2.3%)
Mar 2006
-
$52.40M(-2.2%)
Dec 2005
$53.59M(-9.9%)
$53.59M(-2.5%)
Sep 2005
-
$54.94M(-2.6%)
Jun 2005
-
$56.40M(-2.7%)
Mar 2005
-
$57.95M(-2.5%)
Dec 2004
$59.45M(+83.1%)
$59.45M(-7.0%)
Sep 2004
-
$63.95M(+16.4%)
Jun 2004
-
$54.93M(+27.5%)
Mar 2004
-
$43.10M(+32.7%)
Dec 2003
$32.47M(+515.4%)
$32.47M(+70.0%)
Sep 2003
-
$19.11M(-0.1%)
Jun 2003
-
$19.12M(+256.6%)
Mar 2003
-
$5.36M(+1.6%)
Dec 2002
$5.28M(+46.6%)
$5.28M(+18.0%)
Sep 2002
-
$4.47M(+23.1%)
Jun 2002
-
$3.63M(+12.6%)
Mar 2002
-
$3.23M(-10.3%)
Dec 2001
$3.60M(+57.7%)
$3.60M(+76.3%)
Sep 2001
-
$2.04M(-15.7%)
Jun 2001
-
$2.42M(+22.6%)
Mar 2001
-
$1.98M(-13.4%)
Dec 2000
$2.28M(+8.7%)
$2.28M(+19.5%)
Sep 2000
-
$1.91M(+17.4%)
Jun 2000
-
$1.63M(-13.6%)
Mar 2000
-
$1.88M(-10.3%)
Dec 1999
$2.10M(-4.5%)
$2.10M(-4.5%)
Sep 1999
-
$2.20M(-4.3%)
Jun 1999
-
$2.30M(+9.5%)
Mar 1999
-
$2.10M(-4.5%)
Dec 1998
$2.20M(+214.3%)
$2.20M(+214.3%)
Dec 1997
$700.00K(-12.5%)
$700.00K(-12.5%)
Dec 1996
$800.00K
$800.00K(-42.9%)
Mar 1996
-
$1.40M

FAQ

  • What is Neurocrine Biosciences annual long term debt?
  • What is the all time high annual long term debt for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual long term debt year-on-year change?
  • What is Neurocrine Biosciences quarterly long term debt?
  • What is the all time high quarterly long term debt for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly long term debt year-on-year change?

What is Neurocrine Biosciences annual long term debt?

The current annual long term debt of NBIX is $455.10M

What is the all time high annual long term debt for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual long term debt is $455.10M

What is Neurocrine Biosciences annual long term debt year-on-year change?

Over the past year, NBIX annual long term debt has changed by +$196.80M (+76.19%)

What is Neurocrine Biosciences quarterly long term debt?

The current quarterly long term debt of NBIX is $447.50M

What is the all time high quarterly long term debt for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly long term debt is $499.70M

What is Neurocrine Biosciences quarterly long term debt year-on-year change?

Over the past year, NBIX quarterly long term debt has changed by +$194.60M (+76.95%)
On this page